Shares of Sunshine Biopharma, Inc. (NASDAQ:SBFMW – Get Free Report) shot up 27% during mid-day trading on Tuesday . The company traded as high as $0.3138 and last traded at $0.24. 500 shares traded hands during trading, a decline of 96% from the average session volume of 12,681 shares. The stock had previously closed at $0.1890.
Sunshine Biopharma Stock Up 27.0%
The firm has a 50 day moving average price of $0.23 and a 200 day moving average price of $0.22.
About Sunshine Biopharma
Sunshine Biopharma is a development-stage biopharmaceutical company focused on the discovery and development of novel small-molecule therapeutics for oncology and antiviral applications. The company’s research activities encompass the design, synthesis and preclinical evaluation of compounds that inhibit key pathways involved in cell proliferation and viral replication.
Among its lead programs, Sunshine Biopharma is advancing Adva-27a, a topoisomerase II inhibitor licensed from the National Research Council of Canada, which is undergoing preclinical studies for potential use in breast and ovarian cancers.
Further Reading
- Five stocks we like better than Sunshine Biopharma
- The boring AI play that could pay up to $4,290 monthly
- ALERT: Drop these 5 stocks before January 2026!
- Trump’s “real estate deal for America” explained
- A month before the crash
- Put $1,000 into this stock by Jan 1 [Not NVDA]
Receive News & Ratings for Sunshine Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sunshine Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
